Clinico-pathological correlation and prognostic significance of nuclear p53 protein in colorectal cancer

Italian Journal of Gastroenterology

Volumn 28, Issue 4, 1996, Pages 205-210

  Fante, R ^a,b   Di Gregorio, C ^a   Losi, L ^a   Roncucci, L ^a   De Leon, M Ponz ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b Div di Anat E Istologia Patologica   (Italy)

Author keywords

Colorectal cancer; Immunohistochemistry; Nuclear p53; Survival

Indexed keywords

PROTEIN P53;

ADULT; ARTICLE; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL FEATURE; COLON ADENOCARCINOMA; COLORECTAL CARCINOMA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; ITALY; MAJOR CLINICAL STUDY; MALE; PATHOLOGY; PROGNOSIS; SURVIVAL RATE;

ADENOCARCINOMA; AGED; COLORECTAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PROGNOSIS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0029976610     PISSN: 03920623     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Lane DP, Benchimol S. p53: Oncogene or antioncogene? Genes Dev 1990; 4: 1-8.
2. Lehman TA, Bennett WP, Metcalf RA, Reddel JA, Ecker J, Modali RV, et al. p53 mutations, ras mutations and p53-heat shock protein complexes in human lung cell lines. Cancer Res 1991; 51: 4090-6.
3. Levine AJ, Momand J, Finlay CA. The p53 tumor suppressor gene. Nature 1991; 351: 453-6.
4. Rodrigues NR, Rowan A, Smith ME, Kerr IB, Bodmer WF, Cannon JV, et al. p53 mutations in colorectal can-cer. Proc Natl Acad Sci USA 1990; 87: 7555-9.
5. Kawasaki Y, Monden T, Morimoto H, Murotani M, Miyoshi Y, Kobayashi T, et al. Immunohistochemical study of p53 expression in microwave-fixed, paraffin-embedded sections of colorectal carcinoma and adenoma. Am J Clin Pathol 1992; 97: 244-9.
6. Bruner JM, Connelly JH, Saya H. p53 immunostaining in routinely processed paraffin-embedded sections. Mod Pathol 1992; 6: 189-94.
7. Losi L, Di Gregorio C, Brausi M, Fante R, Hurlimann J. Expression of p53 protein in prostate cancers of different histologic types. Path Res Pract 1994; 190: 384-8.
8. Hollstein M, Sidranski D, Vogelstein B, Harris CC. p53 mutations in human cancers. Science 1991; 253: 49-53.
9. Baker SJ, Fearon ER, Nigro JM, Hamilton SR, Preisinger AC, Jessup JM, et al. Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. Science 1988; 244: 217-21.
10. Cunningham J, Lust JA, Schaid DJ, Bren GD, Carpenter HA, Rizza E, et al. Expression of p53 and 17p allelic loss in colorectal carcinoma. Cancer Res 1992; 52: 1974-80.
11. Purdie CA, O'Grady J, Piris J, Wyllie AH, Bird CC. p53 expression in colorectal tumors. Am J Pathol 1991; 138: 807-13.
12. Scott N, Sagar P, Stewart J, Blair GE, Dixon MF, Quirke P. p53 in colorectal cancer: clinicopathological correlation and prognostic significance. Br J Cancer 1991; 63: 317-9.
13. Remvikos Y, Tominaga O, Hammel P, Laurent-Puig P, Salmon RJ, Dutrillaux B, et al. Increased p53 protein content of colorectal tumors correlates with poor survival. Br J Cancer 1992; 66: 758-64.
14. Bell SM, Scott N, Cross D, Sagar P, Lewis FA, Blair GE, et al. Prognostic value of p53 overexpression and c-Ki-ras gene mutations in colorectal cancer. Gastroenterology 1993; 104: 57-64.
15. Yamaguchi A, Kurosaka Y, Fushida S, Kanno M, Yonemura Y, Miwa K, et al. Expression of p53 protein in colorectal cancer and its relationship to short-term prognosis. Cancer 1992; 70: 2778-84.
16. Yamaguchi A, Nakagawara G, Kurosaka Y, Nishimura G, Yonemura Y, Miyazaki I. p53 immunoreaction in endoscopic biopsy specimens of colorectal cancer, and its prognostic significance. Br J Cancer 1993; 68: 399-402.
17. Sun X-F, Carstensen JM, Zhang H, Stal O, Wingren S, Hatschek T, et al. Prognostic significance of cytoplasmic p53 oncoprotein in colorectal adenocarcinoma. Lancet 1992; 340: 1369-73.
18. Meling GI, Lothe RA, Børresen AL, Graue C, Hauge S, Clause OPF, et al. The TP53 tumor suppressor gene in colorectal carcinomas. II. Relation to DNA ploidy pattern and clinicopathological variables. Br J Cancer 1993; 67: 93-8.
19. Bosari S, Viale G, Bossi P, Maggioni M, Coggi G, Murray JJ, et al. Cytoplasmic accumulation of p53 protein: an independent prognostic indicator in colorectal adenocarcinomas. J Natl Cancer Inst 1994; 86: 681-7.
20. Hannisdal E, Thorsen G. Regression analysis of pro-gnostic factors in colorectal cancer. J Surg Oncol 1988; 37: 109-12.
21. Wiggers T, Arends JW, Schutte B, Volovics L, Bosman FT. A multivariate analysis of pathologic prognostic indicators in large bowel cancer. Cancer 1988; 61: 386-95.
22. Ponz de Leon M, Sant M, Micheli A, Sacchetti C, Di Gregorio C, Fante R, et al. Clinical and pathologic prognostic indicators in colorectal cancer. A population-based study. Cancer 1992; 69: 626-35.
23. Banks L, Matlashewski G, Crawford L. Isolation of human-p53 specific monoclonal antibodies and their use in the studies of human p53 expression. Eur J Biochem 1986; 159: 529-34.
24. Weisburger JH, Wynder EL. Etiology of colorectal cancer with particular emphasis on mechanisms of action and prevention. In: Important Advances in Oncology, De Vita VT, Hellman S, Rosenberg SA (eds). New York: Lippincott, 1987: 197.
25. Ponz de Leon M, Sacchetti C, Sassatelli R, Zanghieri G, Roncucci L, Scalmati A. Evidence for the existence of different types of large bowel tumor: suggestions from the clinical data of a population-based registry. J Surg Oncol 1990; 44: 35-43.
26. Arbman G, Axelson O, Fredriksson M, Nilsson E, Sjdahl R. Do occupational factors influence the risk of colon and rectal cancer in different ways? Cancer 1993; 72: 2543-9.
27. Berrino F, Sant M, Verdecchia A, Capocaccia R, Hakulinen T, Esteve J. Cancer survival in Europe. IARC Sci Pub n. 132, Lyon, International Agency for Research on Cancer 1994.
28. Auvinen A, Isola J, Visakorpi T, Koivula T, Virtanen S, Hakama M. Overexpression of p53 and long-term survival in colon carcinoma. Br J Cancer 1994; 70: 293-6.
29. Starzynska T, Bromley M, Ghosh A, Stern PL. Prognostic significance of p53 overexpression in gastric and colorectal carcinoma. Br J Cancer 1992; 66: 558-62.
30. Baas IO, Mulder JWR, Offerhaus GJA, Vogelstein B, Hamilton SR. An evaluation of six antibodies for immunohistochemistry of mutant p53 gene product in archival colorectal neoplasms. J Pathol 1994; 172: 5-12.
31. Ohue M, Tomita N, Monden T, Fujita M, Fukunaga M, Takami K, et al. A frequent alteration of p53 gene in carcinoma in adenoma of colon. Cancer Res 1994; 54: 4798-804.
32. Wu X, Boyle JH, Olson DC, Levine AJ. The p53-mdm2 autoregulatory feedback loop. Genes Dev 1993; 7:1126-32.
33. Hall PA, Lane DP. p53 in tumor pathology: can we trust immunohistochemistry? -Revisited! J Pathol 1994; 172: 1-4.